12/2026・Trifork Group: Conclusion Of Share Buyback
| Date | Number of shares | Average purchase price (DKK) | Transaction value (DKK) |
| Total beginning | 146,184 | 91.16 | 13,326,322 |
| 23 February 2026 | 2,700 | 83.62 | 225,774 |
| 24 February 2026 | 2,500 | 80.38 | 200,950 |
| 25 February 2026 | 2,500 | 80.48 | 201,200 |
| 26 February 2026 | 2,500 | 82.81 | 207,025 |
| Accumulated | 156,384 | 90.55 | 14,161,271 |
A detailed overview of the daily transactions can be found here: .
Since the share buyback program was started on 23 December 2025, the total number of repurchased shares is 156,384 at a total amount of DKK 14,161,271.
In week 9, 1,070 shares acquired through the share buyback program were utilized for selected employees' monthly fixed salary, representing a change from cash payment to payment partly in shares.
With the transactions stated above and other transactions since 23 December 2025, Trifork holds a total of 335,483 treasury shares, corresponding to 1.7%. The total number of registered shares in Trifork is 19,744,899. Adjusted for treasury shares, the number of outstanding shares is 19,409,416.
This concludes the share buyback program.
Investor & Media contact
Frederik Svanholm, Group Investment Director,..., +41 79 357 7317
About Trifork Group
Trifork (Nasdaq Copenhagen: TRIFOR) is a pioneering global technology company, empowering enterprise and public sector customers with innovative digital products and solutions. With 1,197 employees in 16 countries, Trifork specializes in designing, building, and operating advanced software in public administration, healthcare, financial services, energy, and aviation. The Group's R&D arm, Trifork Labs, drives innovation by investing in and developing synergistic, high-potential technology companies. Learn more at trifork.
Attachment
-
CA_12_26_Buyback
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment